Cleveland Clinic 10th Annual Basic and Clinical Immunology for the Busy Clinician 2022
$20.00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Cleveland Clinic 10th Annual Basic and Clinical Immunology for the Busy Clinician 2022
Cleveland Clinic
- Include: 18 videos + 14 pdfs , size: 6.87 GB
- Target Audience: rheumatologists; dermatologists; infectious disease clinicians; allergists; clinical immunologists
- Sample video: contact me for sample video
Information:
Cleveland Clinic
Plan to attend this one-of-a-kind symposium that provides a unique array of educational offerings in the field of clinical immunology. This symposium is designed for busy clinicians who desire to increase their declarative and procedural knowledge, as it applies to patient care.
Whether you prefer to join in-person in Scottsdale, AZ, or join by live stream, you will receive instruction from leading experts in the field of immunology. Our Saturday session begins with an overview of advances in immunology, and leads into a review of hot topics in immunology 2023. Our afternoon session focuses on the standard of care for SpA and PsA, along with new developments in treatments for SAPHO, SLE, and complement and vasculitis. On Sunday, our program is devoted to topics related to COVID-19 and rheumatologists/clinical immunologists, including vaccines, long COVID, and cytokine storm. Don’t miss our flipped classroom panel discussion. We’ll conclude the course with a discussion of wellness and treating the COVID-19 patient long-term.
Learning Objectives
By attending, participants will be able to do the following:
- Explain the integrated immune response as it applies to host defense ad immune-mediated diseases and recognize recent advances that may influence patient care.
- Describe and critically appraise the immunologic mechanisms of action for targeted therapies and targeted synthetic therapies regarding the efficacy and safety across the immune mediate inflammatory diseases including psoriatic arthritis (PsA), spondyloarthritis (SpA), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), vasculitis, and others.
- Describe recent advances in prevention and outpatient treatment of COVID-19 in immunocompromised patients, and the use of immune based therapies for hospitalized patients with severe disease.
- Critically appraise data on the role of wellness behaviors on general health, immunologic health, and management of COVID-19 and its complications.
Who Should Attend?
The symposium is directed to rheumatologists; dermatologists; infectious disease clinicians; allergists; clinical immunologists; specialists in integrative medicine, preventive medicine, wellness, and primary care; nurses; physicians assistants, and other health care professionals caring for patients with immunologic diseases.
Topics:
- Autoimmunity and COVID-19 – the new horizon.mp4
- Autoimmunity and COVID-19 – the new horizon.pdf
- Breakthrough COVID on IMIDS.mp4
- Breakthrough COVID on IMIDS.pdf
- COVID-19 and the risks from immunomodulatory therapies.mp4
- COVID-19 and the risks from immunomodulatory therapies.pdf
- COVID-19 at two years- politics, science and challenges.pdf
- COVID-19 Autoimmunity, Prevention and Management- Q&A.mp4
- COVID-19 Round up in Other Immune-Mediated Inflammatory Diseases- Special Considerations Q&A.mp4
- Dermatologic disorders and COVID-19.mp4
- Dermatologic disorders and COVID-19.pdf
- Disease related factors and the risk of infection acquisition and disease progression.mp4
- Disease related factors and the risk of infection acquisition and disease progression.pdf
- IBD and COVID-19.mp4
- IBD and COVID-19.pdf
- In-patient use of immunomodulatory therapies in COVID-19 anti-cytokine antibodies, targeted synthetic.mp4
- In-patient use of immunomodulatory therapies in COVID-19 anti-cytokine antibodies, targeted synthetic.pdf
- JAK inhibitors in the COVID era – assessing risks and benefits.mp4
- JAK inhibitors in the COVID era – assessing risks and benefits.pdf
- Long COVID – what do we know and what should we do.mp4
- Long COVID – what do we know and what should we do.pdf
- Managing COVID-19 in Immune-Mediated Inflammatory Disease Patients- Q&A.mp4
- Multiple Sclerosis and COVID-19.mp4
- Multiple Sclerosis and COVID-19.pdf
- Principles of outpatient management ‘when IMID patient calls with possible COVID’.pdf
- Principles of outpatient management when IMID patient calls with possible COVID.mp4
- Rheumatic Diseases and COVID-19- Challenges for Science in February 2022.mp4
- Rheumatic Diseases and COVID-19- February 2022 Q&A.mp4
- RJ Fasenmyer Center for Clinical immunology Annual Lectureship Understanding immunity and immune memory to SARS-C.mp4
- RJ Fasenmyer Center for Clinical immunology Annual Lectureship Understanding immunity and immune memory to SARS-C.pdf
- Vaccine response in IMIDS – challenges and strategies.mp4
- Vaccine response in IMIDS – challenges and strategies.pdf
Related products
Critical Care \ Emergency medicine